PPIST03225
Protein Information
| Protein_Chain | A;B |
|---|---|
| Protein_Sequence | MASMTGGQQMGAPITAYAQQTRGLLGCIITSLTGRDKNQVEGEVQIVSTATQTFLATCINGVCWTVYHGAGTRTIASPKGPVIQMYTNVDQDLVGWPAPQGSRSLTPCTCGSSDLYLVTRHADVIPVRRRGDSRGSLLSPRPISYLKGSAGGPLLCPAGHAVGLFRAAVCTRGVAKAVDFIPVENLETTMRSGSHHHHHH |
Peptide Information
| Peptide_Chain | C;D |
|---|---|
| Peptide_Sequence | KKGCVVIVGRIVLSGKPAIIPKK |
| Peptide_Length | 23 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 2O8M |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.00 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization |
|---|---|
| Release_Year | 2007 |
| PMID | 17444623 |
| DOI | 10.1021/jm060173k |